MolNFT v1 · #154084 · protein
Crystal structures of endo-beta-1,4-xylanase II complexed with xylotriose
6JZP · Endo-1,4-beta-xylanase 2: “Crystal structures of endo-beta-1,4-xylanase II complexed with xylotriose”. X-ray diffraction, 1 ligand (IOD), 1 pocket (best druggability 0.55). MolNFT v1 #154084 on GenesisL1: 3D structure, binding sites…
- PDB
- 6JZP
- Type
- protein
- Length
- 189 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Endo-1,4-beta-xylanase 2
- EC
- 3.2.1.8
- UniProt
- P36217
- Ligands
- IOD
- Pockets
- 1 · best druggability 0.55
Structure
x-ray diffraction · 1 distinct chain · 5% helix, 61% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Endo-1,4-beta-xylanase 2 (EC 3.2.1.8) | protein | 189 | 5% helix, 61% strand | P36217 |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 246 | 0.55 | 0.77 | 28 | empty |
Modifications
Observed in the structure: 1 covalent (additive adduct).
Compared structures
- 6JZP · Crystal Structures of Endo-beta-1,4-xylanase II Complexed with Xylotriose · the same entry in another collection · chain A against A, TM-score 1.00
- P36217 · AlphaFold monomer V2.0 prediction for endo-1,4-beta-xylanase 2 (P36217) · a predicted model of the same protein · chain A against A, TM-score 0.99
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P36217
- Elsewhere: RCSB PDB 6JZP · PDBe 6JZP · UniProt P36217
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.